Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M. R. Baghaeipour"'
Autor:
B. khoeiny, R. Fayazfar, Gh. Toogeh, Mohammad Faranoush, Mehran Karimi, Hassan Abolghasemi, K. Kamyar, B. Keikhaei Dehdezi, Majid Naderi, N B Mirbehbahani, Hamid Hoorfar, Peyman Eshghi, M. R. Baghaeipour, Fereidoun Mahboudi, R. Heshmat, Mohammadreza Managhchi, Minoo Ahmadinejad, B. Vaziri, Azim Mehrvar
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 22(2)
Introduction: This study compared the efficacy of Aryoseven with Novoseven to control bleeding episodes in patients with hemophilia A with inhibitors. Methods: Sixty-six patients were randomized into 2 groups, with 4 consecutive block randomization.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215b6d61082844e0bd71e4e14744085d
https://pubmed.ncbi.nlm.nih.gov/25343955
https://pubmed.ncbi.nlm.nih.gov/25343955
Autor:
M. R. Baghaeipour, Hamid Hoorfar, Peyman Eshghi, Majid Naderi, Gh. Toogeh, Minoo Ahmadinejad, Mohammadreza Managhchi, Azim Mehrvar, N B Mirbehbahani, B. khoeiny, R. Heshmat, Mohammad Faranoush, B. Keikhaei Dehdezi, Mehran Karimi, Hassan Abolghasemi, K. Kamyar, R. Fayazfar
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 21(8)
In order to establish the efficacy and biosimilar nature of AryoSeven to NovoSeven in the treatment of congenital factor VII (FVII) deficiency, patients received either agent at 30 μg/kg, intravenously per week for 4 weeks, in a randomized fashion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58fe1a88b08b6a84199908f16ebefc91
https://pubmed.ncbi.nlm.nih.gov/24651301
https://pubmed.ncbi.nlm.nih.gov/24651301